Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH
NCT06297434
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
87
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-alcoholic Steatohepatitis
Interventions
DRUG:
J2H-1702
DRUG:
J2H-1702
DRUG:
J2H-1702
DRUG:
Placebo
Sponsor
J2H Biotech